These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36340146)

  • 21. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
    Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
    Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
    Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug Repurposing Approach for Developing Novel Therapy Against Mupirocin-Resistant
    Mujwar S; Deshmukh R; Harwansh RK; Gupta JK; Gour A
    Assay Drug Dev Technol; 2019 Oct; 17(7):298-309. PubMed ID: 31634019
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of novel potential β-N-acetyl-D-hexosaminidase inhibitors by virtual screening, molecular dynamics simulation and MM-PBSA calculations.
    Liu J; Liu M; Yao Y; Wang J; Li Y; Li G; Wang Y
    Int J Mol Sci; 2012; 13(4):4545-4563. PubMed ID: 22605995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating the molecular mechanism of staphylococcal DNA gyrase inhibitors: A combined ligand-based and structure-based resources pipeline.
    Durdagi S; Tahir Ul Qamar M; Salmas RE; Tariq Q; Anwar F; Ashfaq UA
    J Mol Graph Model; 2018 Oct; 85():122-129. PubMed ID: 30176384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovering inhibitors of TEAD palmitate binding pocket through virtual screening and molecular dynamics simulation.
    Li Y; Li Y; Ning C; Yue J; Zhang C; He X; Wang Y; Liu Z
    Comput Biol Chem; 2022 Jun; 98():107648. PubMed ID: 35288361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of Staphylococcus aureus sortase A inhibitors using virtual screening and the relaxed complex scheme.
    Chan AH; Wereszczynski J; Amer BR; Yi SW; Jung ME; McCammon JA; Clubb RT
    Chem Biol Drug Des; 2013 Oct; 82(4):418-28. PubMed ID: 23701677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Antibacterial Potential of Ciprofloxacin Hybrids against
    Zang W; Li D; Gao L; Gao S; Hao P; Bian H
    Curr Top Med Chem; 2022; 22(12):1020-1034. PubMed ID: 35301951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting druggable enzymome by exploiting natural medicines: An in silico-in vitro integrated approach to combating multidrug resistance in bacterial infection.
    Zang P; Gong A; Zhang P; Yu J
    Pharm Biol; 2016; 54(4):604-18. PubMed ID: 26681298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidrug Intrinsic Resistance Factors in Staphylococcus aureus Identified by Profiling Fitness within High-Diversity Transposon Libraries.
    Rajagopal M; Martin MJ; Santiago M; Lee W; Kos VN; Meredith T; Gilmore MS; Walker S
    mBio; 2016 Aug; 7(4):. PubMed ID: 27531908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clumping factor B, a fibrinogen-binding MSCRAMM (microbial surface components recognizing adhesive matrix molecules) adhesin of Staphylococcus aureus, also binds to the tail region of type I cytokeratin 10.
    Walsh EJ; O'Brien LM; Liang X; Hook M; Foster TJ
    J Biol Chem; 2004 Dec; 279(49):50691-9. PubMed ID: 15385531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An exhaustive yet simple virtual screening campaign against Sortase A from multiple drug resistant Staphylococcus aureus.
    Uddin R; Saeed K
    Mol Biol Rep; 2014 Aug; 41(8):5167-75. PubMed ID: 24797540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hibifolin, a Natural Sortase A Inhibitor, Attenuates the Pathogenicity of Staphylococcus aureus and Enhances the Antibacterial Activity of Cefotaxime.
    Song W; Wang L; Zhao Y; Lanzi G; Wang X; Zhang C; Guan J; Wang W; Guo X; Meng Y; Wang B; Zhao Y
    Microbiol Spectr; 2022 Aug; 10(4):e0095022. PubMed ID: 35913166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.
    Kuok CF; Hoi SO; Hoi CF; Chan CH; Fong IH; Ngok CK; Meng LR; Fong P
    Exp Biol Med (Maywood); 2017 Apr; 242(7):731-743. PubMed ID: 28118725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
    Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin.
    Wu ZC; Boger DL
    Acc Chem Res; 2020 Nov; 53(11):2587-2599. PubMed ID: 33138354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic and genotypic changes of Staphylococcus aureus in the presence of the inappropriate concentration of chlorhexidine gluconate.
    Baseri N; Najar-Peerayeh S; Bakhshi B; Campanile F
    BMC Microbiol; 2022 Apr; 22(1):100. PubMed ID: 35418037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bactericidal Effect of Tomatidine-Tobramycin Combination against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Is Enhanced by Interspecific Small-Molecule Interactions.
    Boulanger S; Mitchell G; Bouarab K; Marsault É; Cantin A; Frost EH; Déziel E; Malouin F
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7458-64. PubMed ID: 26392496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-hepatitis C virus drug simeprevir: a promising antimicrobial agent against MRSA.
    Li Y; She P; Xu L; Liu Y; Liu S; Li Z; Yang Y; Li L; Hussain Z; Wu Y
    Appl Microbiol Biotechnol; 2022 Apr; 106(7):2689-2702. PubMed ID: 35338386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.